Wen‐Hsuan Yang

2.5k total citations · 2 hit papers
18 papers, 1.6k citations indexed

About

Wen‐Hsuan Yang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wen‐Hsuan Yang has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wen‐Hsuan Yang's work include Ferroptosis and cancer prognosis (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and RNA Research and Splicing (5 papers). Wen‐Hsuan Yang is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Hippo pathway signaling and YAP/TAZ (6 papers) and RNA Research and Splicing (5 papers). Wen‐Hsuan Yang collaborates with scholars based in United States, Italy and Taiwan. Wen‐Hsuan Yang's co-authors include Jen‐Tsan Chi, Chien‐Kuang Cornelia Ding, Chao‐Chieh Lin, Jianli Wu, Tianai Sun, Po‐Han Chen, David S. Hsu, Gabrielle Rupprecht, Susan K. Murphy and Zhiqing Huang and has published in prestigious journals such as Oncogene, Cell Death and Differentiation and Cell Reports.

In The Last Decade

Wen‐Hsuan Yang

18 papers receiving 1.6k citations

Hit Papers

The Hippo Pathway Effector TAZ Regulates Ferroptosis in R... 2019 2026 2021 2023 2019 2021 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
    2019 363 citations Wen‐Hsuan Yang, Chien‐Kuang Cornelia Ding et al. Cell Reports profile →
  2. Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy
    2021 192 citations Wen‐Hsuan Yang, Yijian Qiu et al. Trends in cancer profile →

Peers

Wen‐Hsuan Yang
Shingo Ashida Japan
Lian‐Di Liao China
Takefumi Kikuchi Japan
Wensheng Liu China
Linda Xu United States
Shuo Qie United States
Alexander Koch Belgium
Patrick Kwok‐Shing Ng United States
Chengzhen Ren United States
Shingo Ashida Japan
Wen‐Hsuan Yang
Citations per year, relative to Wen‐Hsuan Yang Wen‐Hsuan Yang (= 1×) peers Shingo Ashida

Countries citing papers authored by Wen‐Hsuan Yang

Since Specialization
Citations

This map shows the geographic impact of Wen‐Hsuan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Hsuan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Hsuan Yang more than expected).

Fields of papers citing papers by Wen‐Hsuan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Hsuan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Hsuan Yang. The network helps show where Wen‐Hsuan Yang may publish in the future.

Co-authorship network of co-authors of Wen‐Hsuan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Hsuan Yang. A scholar is included among the top collaborators of Wen‐Hsuan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Hsuan Yang. Wen‐Hsuan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Zifei, Joshua A. Homer, Wen‐Hsuan Yang, et al.. (2023). Inhibition of mitochondrial metabolism by (−)-jerantinine A: synthesis and biological studies in triple-negative breast cancer cells. RSC Medicinal Chemistry. 14(4). 710–714. 1 indexed citations
2.
Jain, Vaibhav, Wen‐Hsuan Yang, Jianli Wu, et al.. (2022). Single Cell RNA-Seq Analysis of Human Red Cells. Frontiers in Physiology. 13. 828700–828700. 20 indexed citations
3.
Chen, Po‐Han, Jianli Wu, Yitong Xu, et al.. (2021). Zinc transporter ZIP7 is a novel determinant of ferroptosis. Cell Death and Disease. 12(2). 198–198. 90 indexed citations
4.
Lin, Chao‐Chieh, Wen‐Hsuan Yang, Yi-Tzu Lin, et al.. (2021). DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Oncogene. 40(11). 2018–2034. 80 indexed citations
5.
Yang, Wen‐Hsuan, et al.. (2021). Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy. Trends in cancer. 7(8). 790–804. 192 indexed citations breakdown →
6.
Du, Kuo, Rajesh Kumar Dutta, Tianai Sun, et al.. (2021). Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells but exacerbates chronic liver injury. Liver International. 41(9). 2214–2227. 47 indexed citations
7.
Yang, Wen‐Hsuan, Chao‐Chieh Lin, Jianli Wu, et al.. (2021). The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2. Molecular Cancer Research. 19(6). 1005–1014. 85 indexed citations
8.
Ding, Chien‐Kuang Cornelia, J.A. Rose, Tianai Sun, et al.. (2020). MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nature Metabolism. 2(3). 270–277. 132 indexed citations
9.
Lin, Chao‐Chieh, Nathaniel W. Mabe, Yi-Tzu Lin, et al.. (2020). RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence. Cell Death and Differentiation. 27(7). 2234–2247. 45 indexed citations
10.
Yang, Wen‐Hsuan, Zhiqing Huang, Jianli Wu, et al.. (2019). A TAZ–ANGPTL4–NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer. Molecular Cancer Research. 18(1). 79–90. 235 indexed citations
11.
Yang, Wen‐Hsuan, Chien‐Kuang Cornelia Ding, Tianai Sun, et al.. (2019). The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. Cell Reports. 28(10). 2501–2508.e4. 363 indexed citations breakdown →
12.
Yang, Wen‐Hsuan & Jen‐Tsan Chi. (2019). Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis. Molecular & Cellular Oncology. 7(1). 1699375–1699375. 60 indexed citations
13.
Park, Han Sang, Will J. Eldridge, Wen‐Hsuan Yang, et al.. (2019). Quantitative phase imaging of erythrocytes under microfluidic constriction in a high refractive index medium reveals water content changes. Microsystems & Nanoengineering. 5(1). 63–63. 21 indexed citations
14.
Chen, Po‐Han, Jianli Wu, Chien‐Kuang Cornelia Ding, et al.. (2019). Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism. Cell Death and Differentiation. 27(3). 1008–1022. 225 indexed citations
15.
Yang, Wen‐Hsuan, et al.. (2019). The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. SSRN Electronic Journal. 9 indexed citations
16.
Yang, Wen‐Hsuan, et al.. (2018). miR-132 weakens proliferation and invasion of glioma cells via the inhibition of Gli1.. PubMed. 22(7). 1971–1978. 10 indexed citations
17.
Yang, Wen‐Hsuan, et al.. (2012). Differential Expression and Functional Analysis of the Tristetraprolin Family during Early Differentiation of 3T3-L1 Preadipocytes. International Journal of Biological Sciences. 8(5). 761–777. 13 indexed citations
18.
Yang, Wen‐Hsuan, et al.. (2012). Drosophila eyes absent is a Novel mRNA Target of the Tristetraprolin (TTP) Protein DTIS11. International Journal of Biological Sciences. 8(5). 606–619. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shingo Ashida Breakdown of academic impact, for papers by Lian‐Di Liao Breakdown of academic impact, for papers by Takefumi Kikuchi Breakdown of academic impact, for papers by Wensheng Liu Breakdown of academic impact, for papers by Linda Xu Breakdown of academic impact, for papers by Shuo Qie Breakdown of academic impact, for papers by Alexander Koch Breakdown of academic impact, for papers by Patrick Kwok‐Shing Ng Breakdown of academic impact, for papers by Chengzhen Ren
Rankless by CCL
2026